These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 11389066)

  • 1. 111In-labeled 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid-lys(8)-vasotocin: a new powerful radioligand for oxytocin receptor-expressing tumors.
    Bussolati G; Chinol M; Chini B; Nacca A; Cassoni P; Paganelli G
    Cancer Res; 2001 Jun; 61(11):4393-7. PubMed ID: 11389066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved radiotracing of oxytocin receptor-expressing tumours using the new [111In]-DOTA-Lys8-deamino-vasotocin analogue.
    Chini B; Chinol M; Cassoni P; Papi S; Reversi A; Areces L; Marrocco T; Paganelli G; Manning M; Bussolati G
    Br J Cancer; 2003 Sep; 89(5):930-6. PubMed ID: 12942128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of linker variation on the in vitro and in vivo characteristics of an 111In-labeled RGD peptide.
    Dijkgraaf I; Liu S; Kruijtzer JA; Soede AC; Oyen WJ; Liskamp RM; Corstens FH; Boerman OC
    Nucl Med Biol; 2007 Jan; 34(1):29-35. PubMed ID: 17210459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and in vitro evaluation of an 111In-labeled ST-peptide enterotoxin (ST) analogue for specific targeting of guanylin receptors on human colonic cancers.
    Gali H; Sieckman GL; Hoffman TJ; Kiefer GE; Chin DT; Forte LR; Volkert WA
    Anticancer Res; 2001; 21(4A):2785-92. PubMed ID: 11724355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facile synthesis and evaluation of C-functionalized benzyl-1-oxa-4,7,10-triazacyclododecane-N,N',N″-triacetic acid as chelating agent for ¹¹¹In-labeled polypeptides.
    Suzuki H; Kanai A; Uehara T; Guerra Gomez FL; Hanaoka H; Arano Y
    Bioorg Med Chem; 2012 Jan; 20(2):978-84. PubMed ID: 22178661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiolabeled divalent peptidomimetic vitronectin receptor antagonists as potential tumor radiotherapeutic and imaging agents.
    Harris TD; Cheesman E; Harris AR; Sachleben R; Edwards DS; Liu S; Bartis J; Ellars C; Onthank D; Yalamanchili P; Heminway S; Silva P; Robinson S; Lazewatsky J; Rajopadhye M; Barrett J
    Bioconjug Chem; 2007; 18(4):1266-79. PubMed ID: 17579472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors.
    Zhang H; Chen J; Waldherr C; Hinni K; Waser B; Reubi JC; Maecke HR
    Cancer Res; 2004 Sep; 64(18):6707-15. PubMed ID: 15374988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical comparison in AR4-2J tumor-bearing mice of four radiolabeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-somatostatin analogs for tumor diagnosis and internal radiotherapy.
    Froidevaux S; Heppeler A; Eberle AN; Meier AM; Häusler M; Beglinger C; Béhé M; Powell P; Mäcke HR
    Endocrinology; 2000 Sep; 141(9):3304-12. PubMed ID: 10965902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of potent alphavbeta3-integrin receptor antagonists.
    Dijkgraaf I; Kruijtzer JA; Frielink C; Soede AC; Hilbers HW; Oyen WJ; Corstens FH; Liskamp RM; Boerman OC
    Nucl Med Biol; 2006 Nov; 33(8):953-61. PubMed ID: 17127167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of chelate conjugation on a newly identified tumor-targeting peptide.
    Mier W; Zitzmann S; Krämer S; Reed J; Knapp EM; Altmann A; Eisenhut M; Haberkorn U
    J Nucl Med; 2007 Sep; 48(9):1545-52. PubMed ID: 17704241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization Strategies for Linear Minigastrin Analogues: Further Improvements
    Klingler M; Hörmann AA; Rangger C; Desrues L; Castel H; Gandolfo P; von Guggenberg E
    J Med Chem; 2020 Dec; 63(23):14668-14679. PubMed ID: 33226806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DOTA-lanreotide: a novel somatostatin analog for tumor diagnosis and therapy.
    Smith-Jones PM; Bischof C; Leimer M; Gludovacz D; Angelberger P; Pangerl T; Peck-Radosavljevic M; Hamilton G; Kaserer K; Kofler A; Schlangbauer-Wadl H; Traub T; Virgolini I
    Endocrinology; 1999 Nov; 140(11):5136-48. PubMed ID: 10537142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prelabeling of chimeric monoclonal antibody L6 with 90yttrium- and 111indium-1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA) chelates for radioimmunodiagnosis and therapy.
    Li M; Meares CF; Salako Q; Kukis DL; Zhong GR; Miers L; DeNardo SJ
    Cancer Res; 1995 Dec; 55(23 Suppl):5726s-5728s. PubMed ID: 7493335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxytocin receptor within the breast: biological function and distribution.
    Sapino A; Cassoni P; Stella A; Bussolati G
    Anticancer Res; 1998; 18(3C):2181-6. PubMed ID: 9703781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiolabelling of glucose-Tyr3-octreotate with 125I and analysis of its metabolism in rats: comparison with radiolabelled DOTA-Tyr3-octreotate.
    Petrik M; Laznickova A; Laznicek M; Zalutsky MR
    Anticancer Res; 2007; 27(6B):3941-6. PubMed ID: 18225554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodistribution of 111In- and 90Y-labeled DOTA and maleimidocysteineamido-DOTA conjugated to chimeric anticarcinoembryonic antigen antibody in xenograft-bearing nude mice: comparison of stable and chemically labile linker systems.
    Williams LE; Lewis MR; Bebb GG; Clarke KG; Odom-Maryon TL; Shively JE; Raubitschek AA
    Bioconjug Chem; 1998; 9(1):87-93. PubMed ID: 9460550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 90Y-DOTA-hLL2: an agent for radioimmunotherapy of non-Hodgkin's lymphoma.
    Griffiths GL; Govindan SV; Sharkey RM; Fisher DR; Goldenberg DM
    J Nucl Med; 2003 Jan; 44(1):77-84. PubMed ID: 12515879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular imaging of bcl-2 expression in small lymphocytic lymphoma using 111In-labeled PNA-peptide conjugates.
    Jia F; Figueroa SD; Gallazzi F; Balaji BS; Hannink M; Lever SZ; Hoffman TJ; Lewis MR
    J Nucl Med; 2008 Mar; 49(3):430-8. PubMed ID: 18287262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiolabeling of HTE1PA: A new monopicolinate cyclam derivative for Cu-64 phenotypic imaging. In vitro and in vivo stability studies in mice.
    Frindel M; Camus N; Rauscher A; Bourgeois M; Alliot C; Barré L; Gestin JF; Tripier R; Faivre-Chauvet A
    Nucl Med Biol; 2014 May; 41 Suppl():e49-57. PubMed ID: 24440584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of functionalised HP-DO3A chelating agents for conjugation to biomolecules.
    Barge A; Cappelletti E; Cravotto G; Ferrigato A; Lattuada L; Marinoni F; Tei L
    Org Biomol Chem; 2009 Sep; 7(18):3810-6. PubMed ID: 19707687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.